TERN
Terns Pharmaceuticals, Inc. · Healthcare
Vivo Opportunity, LLC sold $2.8M of Terns Pharmaceuticals, Inc.
10% owner
Sold$2,796,859
$6.65Price
420,663Shares
−6%Stake
What TERN did after the filing
- The stock from Thu, Apr 4 open, $6.07
- +1.2%
- S&P 500, same days
- +1.0%
Measured over 30 trading days, to the May 16 close.
Traded Mon, Apr 1. Filed Wed, Apr 3, 4:47 PM ET, after the close. Returns use the Apr 4 open and the May 16 close. Not investment advice.